HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsutomu Masaki Selected Research

Messenger RNA (mRNA)

1/2019Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
2/2014Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
1/2014Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
11/2013Aldosterone aggravates glucose intolerance induced by high fructose.
5/2013[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.
2/2012Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
12/2008Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
2/2007Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
10/2005Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
6/2004Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsutomu Masaki Research Topics

Disease

102Neoplasms (Cancer)
08/2022 - 04/2002
69Hepatocellular Carcinoma (Hepatoma)
03/2022 - 02/2002
30Fibrosis (Cirrhosis)
11/2021 - 03/2003
28Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 03/2002
25Hemorrhage
11/2022 - 06/2005
25Liver Diseases (Liver Disease)
07/2021 - 02/2004
22Infections
04/2021 - 02/2009
16Adenocarcinoma
08/2022 - 08/2013
15Pancreatic Neoplasms (Pancreatic Cancer)
08/2022 - 11/2002
15Neoplasm Metastasis (Metastasis)
05/2022 - 05/2003
14Insulin Resistance
01/2021 - 07/2010
14Hypertension (High Blood Pressure)
03/2020 - 10/2011
14Stomach Neoplasms (Stomach Cancer)
01/2020 - 11/2002
12Carcinogenesis
02/2021 - 05/2003
11Necrosis
07/2017 - 09/2002
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2003
9Carcinoma (Carcinomatosis)
02/2022 - 05/2003
9Chronic Hepatitis C
05/2020 - 02/2009
9Ulcer
12/2018 - 12/2012
8Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/2021 - 08/2010
8Cholangiocarcinoma
07/2021 - 02/2009
7Inflammation (Inflammations)
01/2022 - 01/2014
7Wounds and Injuries (Trauma)
02/2021 - 09/2006
7Chronic Hepatitis (Chronic Active Hepatitis)
07/2020 - 05/2004
7Pathologic Constriction (Stenosis)
01/2019 - 09/2011
6Liver Neoplasms (Liver Cancer)
01/2022 - 11/2002
6Type 2 Diabetes Mellitus (MODY)
03/2020 - 01/2013
6Autoimmune Hepatitis
01/2016 - 03/2003
5Fistula
04/2022 - 06/2012
5Albuminuria
01/2019 - 01/2012
5Esophageal Neoplasms (Esophageal Cancer)
06/2018 - 09/2002
5Polyps
11/2017 - 11/2003
4Autoimmune Diseases (Autoimmune Disease)
01/2022 - 06/2002
4Chronic Hepatitis B
06/2021 - 01/2019
4Esophageal Squamous Cell Carcinoma
04/2021 - 05/2019
4Hepatitis
01/2021 - 07/2017
4Anemia
07/2020 - 06/2012
4Ischemia
01/2020 - 09/2006
4Reperfusion Injury
01/2020 - 10/2010
4Hypoxia (Hypoxemia)
01/2018 - 02/2012

Drug/Important Bio-Agent (IBA)

47MicroRNAs (MicroRNA)IBA
04/2022 - 08/2009
30Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2002
18Biomarkers (Surrogate Marker)IBA
09/2022 - 05/2013
14Glucose (Dextrose)FDA LinkGeneric
01/2021 - 07/2010
13Messenger RNA (mRNA)IBA
01/2019 - 06/2003
13Ethanol (Ethyl Alcohol)IBA
06/2014 - 09/2002
12Pharmaceutical PreparationsIBA
01/2022 - 01/2010
12Metformin (Glucophage)FDA LinkGeneric
01/2020 - 03/2012
11SaltsIBA
01/2022 - 01/2012
8Cyclin D1IBA
01/2022 - 03/2003
8Galectins (Galectin)IBA
06/2021 - 05/2013
8ZincIBA
07/2020 - 09/2007
7Sorafenib (BAY 43-9006)FDA Link
12/2021 - 04/2014
7AlbuminsIBA
11/2021 - 01/2013
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2021 - 12/2003
7Antiviral Agents (Antivirals)IBA
05/2021 - 04/2018
7Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2020 - 06/2004
7Phosphotransferases (Kinase)IBA
04/2014 - 03/2003
6AntigensIBA
08/2022 - 10/2005
6Biological ProductsIBA
12/2021 - 11/2003
6AntibodiesIBA
11/2021 - 04/2003
6Hemostatics (Antihemorrhagics)IBA
10/2020 - 08/2012
6Antihypertensive Agents (Antihypertensives)IBA
01/2020 - 01/2013
6Telmisartan (Micardis)FDA Link
01/2020 - 01/2017
6Angiotensin IIIBA
06/2019 - 03/2012
5SodiumIBA
01/2022 - 01/2013
5AldosteroneIBA
01/2022 - 02/2012
5BilirubinIBA
11/2021 - 08/2014
5Prorenin ReceptorIBA
11/2020 - 09/2013
5CyclinsIBA
01/2020 - 04/2002
5CaspasesIBA
01/2018 - 08/2007
5SteroidsIBA
07/2015 - 12/2012
5Insulin (Novolin)FDA Link
09/2014 - 01/2010
5Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2009 - 04/2002
4lenvatinibIBA
03/2022 - 04/2021
4Alanine Transaminase (SGPT)IBA
01/2022 - 10/2010
4Antinuclear AntibodiesIBA
11/2021 - 02/2009
4Keratin-18 (Keratin 18)IBA
06/2021 - 10/2015
4Polyglycolic Acid (Polyglycolide)IBA
03/2021 - 01/2017
4Sodium-Glucose Transporter 2 InhibitorsIBA
07/2020 - 01/2018
4CateninsIBA
01/2020 - 03/2015
4Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2018 - 02/2012
4AutoantibodiesIBA
04/2015 - 10/2005
4tyrosine receptor (receptor, tyrosine)IBA
04/2014 - 01/2010
4olmesartanIBA
05/2013 - 03/2012
4Ethiodized Oil (Ethiodol)FDA Link
08/2007 - 02/2004

Therapy/Procedure

51Therapeutics
11/2022 - 09/2002
25Surgical Instruments (Clip)
04/2022 - 06/2012
15Radiofrequency Ablation
02/2021 - 09/2002
9Drug Therapy (Chemotherapy)
01/2022 - 06/2005
8Neoadjuvant Therapy
08/2022 - 09/2017
6Endoscopic Hemostasis
08/2021 - 06/2005
5Stents
10/2021 - 11/2003
5Traction
03/2021 - 09/2015
4Oral Administration
08/2019 - 05/2005
4Endoscopes
01/2018 - 02/2012
4Gastrectomy
01/2015 - 09/2011
3Ligation
11/2022 - 12/2013
3Minimally Invasive Surgical Procedures
07/2022 - 01/2014
3Renal Dialysis (Hemodialysis)
04/2022 - 01/2016